Articles by Ben Comer - Life Science Leader
WEBJun 14, 2024 · Ben Comer is chief editor of Life Science Leader magazine. He has covered the biopharmaceutical, medtech and medical device industries for 15 years as a reporter and editor, and worked as a senior manager in PwC’s Health Research Institute. Comer was most recently executive editor at In Vivo magazine, where …
An Interview with Robert Hariri MD PhD CEO and founder of …
WEBJan 28, 2020 · At the 2019 CNS Summit, Life Science Leader’s chief editor, Rob Wright, had the opportunity to interview Robert (Bob) Hariri, M.D., Ph.D., CEO and founder of Celularity. Though Hariri was featured in August (How Serial Entrepreneur Robert Hariri Is Revolutionizing Cell Therapy), and the subject of a number of …
Gaurav Shah — A Rare Disease Biopharma CEO Shares A Rare …
WEBFeb 6, 2020 · Gaurav Shah is the CEO of Rocket Pharmaceuticals, a gene therapy company focused on rare diseases. He also leads a band, Falu, that was nominated for a Grammy in 2019 for a children's album.
Merck's Continuous Process Improvement - Life Science Leader
WEBJul 1, 2014 · Merck embraced a process of continuous improvement after years of implementing Lean initiatives that yielded periodic improvements. With Lean, Six Sigma, Kaizen, Agile, total quality management, and other process improvement approaches, after an initial surge, results sometimes slipped backwards to baseline levels.
FDA INTERACT Meetings: Early Interactions For Cell And Gene …
WEBFDA INTERACT Meetings: Early Interactions For Cell And Gene Therapy Sponsors. By Annette F. Arlinghaus, Director, Regulatory Operations and Stacey A. Ayres, PhD Vice President, Regulatory Strategy. Advances in scientific knowledge and growth in the cell and gene therapy space have led to a new and exciting era of medicine for patients, as well ...
The Evolution Of Drug Packaging Redefining Safety And …
WEBMar 13, 2024 · In an era marked by rapid advancements in biotechnology and pharmaceuticals, the evolution of drug packaging stands out as a testament to the industry's commitment to safety, sustainability, and technological innovation. The modern landscape of drug packaging is undergoing a transformation, driven by …
Regulatory Information Management New Technologies To …
WEBDec 6, 2013 · <p>Today’s life sciences industry faces many challenges as drug development costs continue to climb, pricing pressures mount, and new global markets gain critical importance. At the same time, the FDA, EMA, and other regulatory bodies are expanding and amending requirements, clinical trials are becoming more complex, and public disclosure demands are increasing. This increases the ...
Will Pyxis Oncology Be Pfizer's Fourth Billion-Dollar Spinout
WEBJan 4, 2022 · It was late 2015 when Lara Sullivan, M.D., first called me. At the time she was a VP at Pfizer and working closely with Freda Lewis-Hall, M.D., then the company’s chief medical officer. From their vantage point, they could see this tremendous pipeline flow of assets—along with what got funded — and what did not.
Life Science Connect Podcast
WEBListen to podcast episodes featuring biopharmaceutical industry executives, experts, and innovators. Topics include COVID-19, cell and gene therapy, diversity and inclusion, fundraising, and more.
How To Overcome The Challenge Of Valuing A Biotech
WEBDec 30, 2019 · Companies generally use one of three common valuation frameworks to value their company: the net asset value (NAV) method, a form of the cost approach; the discounted cash flow (DCF) method, a form of the income approach; or a market approach. Biotech is better off using the NAV or DCF methods because finding comparables for the market approach ...
Skip to content